STARStrides Pharma Science Ltd.

    Strides Pharma Science Ltd: results and news

    Every Strides Pharma Science Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: earnings.

    1 article · Pharmaceuticals · Latest 29 Oct 2026

    A hand holding a handful of assorted capsules and tablets against a green background

    STARStrides Pharma Science Ltd.

    Strides Pharma Science Q2 FY27 Results: Consolidated Net Profit ₹134 Crore on Total Income of ₹1,434 Crore

    Strides Pharma Science (NSE: STAR) reported consolidated total income of ₹1,433.82 crore and net profit of ₹134.12 crore for the quarter ended 30 Sep 2026, it said in a filing on 29 Oct 2026. Standalone total income was ₹661.29 crore and standalone net profit ₹9.26 crore for the same quarter.

    • Earnings
    • Pharmaceuticals

    Blacklitt Research3 min read